This is what I also believe their business plan/strategy to be. Having said that, all of this clearly implies the company needs much more development time to get to a point of possible revenue generation.
This clearly means things like, we need important things to continue to develop and unfold, like uplisting, starting phase 2 and encountering and reporting interim success along the way. These kind of events, coupled with other possible positive developments in the veterinary field and other promising initiatives yet to enter clinicals, all suggest, imo, the wild speculations and greatly premature and unrealistic share prices folks are posting about, badly need to come back down to earth and better focus on these dynamics that, when they develop, will definitely attract serious and meaningful wall street investment and the hard fact is we are NOT there yet by any means.
What we have is exciting promise and hoped for potential with a promising new management reins, but the wild buying that is being so casually thrown about is not going to happen soon, imo is my conjecture, except some possible buying by he retail investor who almost always, with the exception of a few seasoned smart old timers, will be buying, and possibly chasing in the next couple days, only to be dismayed when they see what the end of the week share price brings. Retail investors become prisoners of their emotions and far, far too often , do the opposite of what they should o, as we know.
As I have felt and posted for quite awhile now, ACTC srikes me clearly as a company with a business plan and strategy to continue to slowly and methodically and carefully grind out, perfect and protect their science and in the process, set up a structure to go it alone if at all possible.
All this takes time, especially when one truly appreciates the incredible negative hurdles, like the very powerful big pharmas, etc., who are NOT sitting back silently, while their billion dollar drugs are under possible serious jeopardy.
Couple this with the other nefarious daily forces like the unrelenting naked shorters, whose volume continues at a staggering pace, and one needs to 'cool it' with their investing dollars and carefully pick their spots to start or add to their positions on appropriate, low-hype, smart times.
All imo, and mean't to help our combined due diligence, thoughts and conjecture.
Market Data 
Markets 
AI
